drugset / Trial / NCT01465919
Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the anti-depressive efficacy of mirtazapine in depression induced by peginterferon alpha-2a and ribavirin treatment in Korean patients with chronic hepatitis C.
Timeline
- Start
- 2011-08
- Primary completion
- 2017-12
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirtazapine | Other / unclassified | 7.5 mg | — |
| Subject | Mirtazapine | Other / unclassified | 45 mg | — |